Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/27/2025FDA Approves China's First Homegrown Painkiller Qamzova
  • 5/27/2025Recce Pharma Secures Key China Patent
  • 5/27/2025Servier Acquires BioNova's Menin Inhibitor BN104
  • 5/27/2025Innovent's Mazdutide Demonstrates Significant Weight Loss in Phase 3 G...
  • 5/27/2025Zai Lab's ZL-1310 Shows Promising Results in Extensive-Stage SCLC
  • 5/27/2025Insilico Medicine Unveils AI-Designed ENPP1 Inhibitor ISM5939
  • 5/27/2025Henlius Reports Promising Phase 1 Results for PD-L1-Targeting ADC HLX4...
  • 5/27/2025CTTQ's Anlotinib Combination Shows Promise
  • 5/27/2025XellSmart's iPSC-Derived Cell Therapy for Spinal Cord Injury Advances ...
  • 5/23/2025Recent Executive Moves
  • 5/23/2025Vigene and Merz Expand Strategic Partnership Across Greater China
  • 5/23/2025Instil Bio and ImmuneOnco Advance PD-L1xVEGF Bispecific Antibody in NS...
  • 5/23/2025CARsgen's Satri-cel CAR T Demonstrates Significant Efficacy in GC/GEJ
  • 5/23/20253SBio's Bispecific Antibody SSGJ-707 Shows Promising Results in Advanc...
  • 5/23/2025Dizal's DZD6008 Shows Promising Results in EGFR-Mutant NSCLC with Brai...
  • 5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo
  • 5/22/2025Hengrui Pharma Raises $1.27B in Hong Kong Listing
  • 5/22/2025InnoVec Secures Series A Funding to Advance AI-Driven Gene Therapy Pla...
  • 5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD
  • 5/22/2025China Approves Raynovent's Onradivir for Adult Influenza A Treatment
  • 5/22/2025NMPA Grants Conditional Approval to JacoBio's Glecirasib for KRAS G12C...
  • 5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...
  • 5/21/2025Accropeutics Reports Phase 2 Psoriasis Success with TYK2/JAK1 Inhibito...
  • 5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare
  • 5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports
  • 5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL
  • 5/21/2025CRISPR and Sirius Forge Strategic Alliance for Next-Gen siRNA Therapy
  • 5/21/2025CureGene Completes Series B+ Financing to Advance Cardiometabolic and ...
  • 5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...
  • 5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...
  • Page:12/54 Total number of articles:1609: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group